LLYNEUTRAL

LLY Return on Equity (ROE) Analysis

102.3%

Higher than 90% of Healthcare sector peers

Updated 125h ago·SEC filings & market data

Key Takeaway

Return on equity (ROE) measures how much profit a company generates from each dollar of shareholders’ money, and Eli Lilly’s current ROE of 102.3% means it is earning more than its entire equity base in a year.

Sector Performance

90th percentile

LLY

102.3%

Sector Median

11.3%

Sector Avg

72.2%

Prior Period

107.5%(Jul 2026)

↓ Declining

📊

Deep Analysis

That figure towers over the healthcare sector median of 8.9%, placing Lilly in the 93rd percentile among its sector peers. The year-over-year change is not available, while the quarter-over-quarter change is -4.8%, and the 8-quarter trend direction is also not available. The combination of an exceptionally high ROE with a slight quarterly decline and no annual comparison suggests strong current profitability but limited evidence of momentum, creating an opportunity for continued outperformance alongside some uncertainty. This metric supports the NEUTRAL verdict: the extreme level argues for positive attention, but the missing trend data and small drop do not justify a more bullish or bearish call.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about LLY?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does LLY's Return on Equity (ROE) compare to its sector?

LLY's Return on Equity (ROE) of 102.3% compares to a Healthcare sector median of 11.3%, placing it in the 90th percentile.

Who are LLY's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: ABT (12.5%), ALGN (10.1%), TMO (13.5%), TECH (9.0%), VEEV (13.9%).

📚

Learn More About Return on Equity (ROE)

What Is Return on Equity (ROE) and Is Higher Always Better?

Return on equity ROE measures how efficiently a company generates profit from shareholder capital. Learn how to decompose ROE using DuPont analysis and why high leverage can make it dangerous—with Apple and JPMorgan examples.

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.